{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:16:58Z","timestamp":1788293818308,"version":"build-2803163510"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,1]]},"DOI":"10.5665\/sleep.5168","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T15:19:54Z","timestamp":1446218394000},"page":"1803-1813","source":"Crossref","is-referenced-by-count":70,"title":["On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers"],"prefix":"10.1093","volume":"38","author":[{"given":"Annemiek","family":"Vermeeren","sequence":"first","affiliation":[{"name":"Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Sun","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric F.P.M.","family":"Vuurman","sequence":"additional","affiliation":[{"name":"Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Jongen","sequence":"additional","affiliation":[{"name":"Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees J.","family":"Van Leeuwen","sequence":"additional","affiliation":[{"name":"Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita C.M.","family":"Van Oers","sequence":"additional","affiliation":[{"name":"Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Palcza","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiadong","family":"Li","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Laethem","sequence":"additional","affiliation":[{"name":"MSD Belgium, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Heirman","sequence":"additional","affiliation":[{"name":"MSD Belgium, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Bautmans","sequence":"additional","affiliation":[{"name":"MSD Belgium, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Troyer","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Wrishko","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"McCrea","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,1]]},"reference":[{"key":"key\n\t\t\t\t2018112204070613300_B1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/11539050-000000000-00000","article-title":"Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence","volume":"34","author":"Dassanayake","year":"2011","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t2018112204070613300_B2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2165\/11533170-000000000-00000","article-title":"The relationship between benzodiazepine use and traffic accidents: a systematic literature review","volume":"24","author":"Smink","year":"2010","journal-title":"CNS Drugs"},{"key":"key\n\t\t\t\t2018112204070613300_B3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00023210-200418050-00003","article-title":"Residual effects of hypnotics: epidemiology and clinical implications","volume":"18","author":"Vermeeren","year":"2004","journal-title":"CNS Drugs"},{"key":"key\n\t\t\t\t2018112204070613300_B4","article-title":"BELSOMRA (suvorexant) prescribing information","author":"Merck & Co. Inc","year":"2014"},{"key":"key\n\t\t\t\t2018112204070613300_B5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/01677063.2011.566953","article-title":"Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist","volume":"25","author":"Winrow","year":"2011","journal-title":"J Neurogenet"},{"key":"key\n\t\t\t\t2018112204070613300_B6","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1021\/jm100541c","article-title":"Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H -1,2,3-triazol-2-yl)phenyl] methanone (MK-4305) for the treatment of insomnia","volume":"53","author":"Cox","year":"2010","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t2018112204070613300_B7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fphar.2014.00016","article-title":"Hypocretin (orexin) regulation of sleep-to-wake transitions","volume":"5","author":"de Lecea","year":"2014","journal-title":"Front Pharmacol"},{"key":"key\n\t\t\t\t2018112204070613300_B8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.smrv.2009.04.002","article-title":"The hyperarousal model of insomnia: a review of the concept and its evidence","volume":"14","author":"Riemann","year":"2010","journal-title":"Sleep Med Rev"},{"key":"key\n\t\t\t\t2018112204070613300_B9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1474-4422(13)70311-9","article-title":"Orexin receptor antagonists: a new treatment for insomnia?","volume":"13","author":"Riemann","year":"2014","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t2018112204070613300_B10","first-page":"259","article-title":"Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men","volume":"36","author":"Sun","year":"2013","journal-title":"Sleep"},{"key":"key\n\t\t\t\t2018112204070613300_B11","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","article-title":"Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant","volume":"79","author":"Herring","year":"2012","journal-title":"Neurology"},{"key":"key\n\t\t\t\t2018112204070613300_B12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1474-4422(14)70053-5","article-title":"Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial","volume":"13","author":"Michelson","year":"2014","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t2018112204070613300_B13","article-title":"Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials","author":"Herring","year":"2014","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2018112204070613300_B14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2202-14-90","article-title":"The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold","volume":"14","author":"Gotter","year":"2013","journal-title":"BMC Neurosci"},{"key":"key\n\t\t\t\t2018112204070613300_B15","doi-asserted-by":"crossref","first-page":"121S","DOI":"10.1111\/j.1365-2125.1984.tb02590.x","article-title":"Driving performance under the influence of drugs: rationale for, and application of, a new test","volume":"18","author":"O'Hanlon","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t2018112204070613300_B16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5665\/sleep.3482","article-title":"Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use","volume":"37","author":"Vermeeren","year":"2014","journal-title":"Sleep"},{"key":"key\n\t\t\t\t2018112204070613300_B17","first-page":"183","article-title":"The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel","volume-title":"International Congress on Alcohol, Drugs and Traffic Safety","author":"Louwerens","year":"1987"},{"key":"key\n\t\t\t\t2018112204070613300_B18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clinthera.2013.11.005","article-title":"Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies","volume":"36","author":"Leufkens","year":"2014","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t2018112204070613300_B19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00213-010-2149-4","article-title":"Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype","volume":"215","author":"Ramaekers","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t2018112204070613300_B20","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.5665\/SLEEP.1272","article-title":"Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects","volume":"34","author":"Mets","year":"2011","journal-title":"Sleep"},{"key":"key\n\t\t\t\t2018112204070613300_B21","first-page":"2785","article-title":"Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study","volume":"231","author":"Leufkens","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t2018112204070613300_B22","volume-title":"L'examen clinique en psychologie","author":"Rey","year":"1964"},{"key":"key\n\t\t\t\t2018112204070613300_B23","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/(SICI)1099-1077(1998110)13:2+<S98::AID-HUP54>3.0.CO;2-1","article-title":"Effects of evening and middle of the night doses of zaleplon 10 and 20 mg on memory and actual driving performance","volume":"13","author":"Vermeeren","year":"1998","journal-title":"Hum Psychopharmacol"},{"key":"key\n\t\t\t\t2018112204070613300_B24","first-page":"224","article-title":"Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol","volume":"25","author":"Vermeeren","year":"2002","journal-title":"Sleep"},{"key":"key\n\t\t\t\t2018112204070613300_B25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2869.2009.00746.x","article-title":"Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem","volume":"18","author":"Leufkens","year":"2009","journal-title":"J Sleep Res"},{"key":"key\n\t\t\t\t2018112204070613300_B26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/JCP.0b013e3181b57b43","article-title":"Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo","volume":"29","author":"Leufkens","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t2018112204070613300_B27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2125.2008.03331.x","article-title":"Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects","volume":"67","author":"Boyle","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t2018112204070613300_B28","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jbiomech.2004.06.014","article-title":"Ability of static and statistical mechanics posturographic measures to distinguish between age and fall risk","volume":"38","author":"Norris","year":"2005","journal-title":"J Biomech"},{"key":"key\n\t\t\t\t2018112204070613300_B29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/hup.2219","article-title":"Effects of prolonged-release melatonin and zolpidem on postural stability in older adults","volume":"27","author":"Otmani","year":"2012","journal-title":"Hum Psychopharmacol"},{"key":"key\n\t\t\t\t2018112204070613300_B30","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s00213-013-3408-y","article-title":"Alcohol calibration of tests measuring skills related to car driving","volume":"231","author":"Jongen","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t2018112204070613300_B31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004714-199906000-00003","article-title":"Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic","volume":"19","author":"Ramaekers","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t2018112204070613300_B32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","article-title":"The use of analogue scales in rating subjective feelings","volume":"47","author":"Bond","year":"1974","journal-title":"Br J Med Psychol"},{"key":"key\n\t\t\t\t2018112204070613300_B33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.smrv.2012.05.004","article-title":"Blood drug concentrations of benzodiazepines correlate poorly with actual driving impairment","volume":"17","author":"Verster","year":"2013","journal-title":"Sleep Med Rev"},{"key":"key\n\t\t\t\t2018112204070613300_B34","first-page":"161","article-title":"Is behavioral tolerance learned?","volume":"21","author":"Vogel-Sprott","year":"1997","journal-title":"Alcohol Health Res World"},{"key":"key\n\t\t\t\t2018112204070613300_B35","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00213-011-2400-7","article-title":"Drivers can poorly predict their own driving impairment: a comparison between measurements of subjective and objective driving quality","volume":"219","author":"Verster","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t2018112204070613300_B36","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.aap.2011.09.003","article-title":"The prevalence and nature of stopped on-the-road driving tests and the relationship with objective performance impairment","volume":"45","author":"Verster","year":"2012","journal-title":"Accid Anal Prev"},{"key":"key\n\t\t\t\t2018112204070613300_B37","first-page":"47","article-title":"Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo","volume":"21","author":"Vermeeren","year":"1995","journal-title":"Acta Ther"},{"key":"key\n\t\t\t\t2018112204070613300_B38","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1002\/(SICI)1099-1077(1998110)13:2+<S79::AID-HUP52>3.0.CO;2-C","article-title":"Residual effects an actual car driving of evening dosing of chlorpheniramine 8 and 12 mg when used with terfenadine 60 mg in the morning","volume":"13","author":"Vermeeren","year":"1998","journal-title":"Hum Psychopharmacol"},{"key":"key\n\t\t\t\t2018112204070613300_B39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hup.470070502","article-title":"A comparative study of on-the-road and simulated driving performance after nocturnal treatment with lormetazepam 1 mg and oxazepam 50 mg","volume":"7","author":"Volkerts","year":"1992","journal-title":"Hum Psychopharmacol"},{"key":"key\n\t\t\t\t2018112204070613300_B40","first-page":"2851","article-title":"On-the-road driving performance and driving related skills in older untreated insomnia patients and chronic users of hypnotics","volume":"231","author":"Leufkens","year":"2014","journal-title":"Psychopharmacology"},{"key":"key\n\t\t\t\t2018112204070613300_B41","volume-title":"The role of the drinking driver in traffic accidents","author":"Borkenstein","year":"1964"},{"key":"key\n\t\t\t\t2018112204070613300_B42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0001-4575(02)00134-3","article-title":"The alcohol-related accident risk in Germany: procedure, methods and results","volume":"36","author":"Kr\u00fcger","year":"2004","journal-title":"Accid Anal Prev"}],"container-title":["Sleep"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/sleep\/article-pdf\/38\/11\/1803\/26671241\/aasm.38.11.1803.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:24:00Z","timestamp":1567297440000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article\/38\/11\/1803\/2662289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,1]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,1]]},"published-print":{"date-parts":[[2015,11,1]]}},"URL":"https:\/\/doi.org\/10.5665\/sleep.5168","relation":{},"ISSN":["1550-9109","0161-8105"],"issn-type":[{"value":"1550-9109","type":"electronic"},{"value":"0161-8105","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,11]]},"published":{"date-parts":[[2015,11,1]]}}}